Plexus Research, a division of GP InnoVentures (GPIV), an investment and innovation organization based in Adelaide, Australia, is joining the TriNetX global health research network, to help generate greater access to clinical trials and provide a path to market for groundbreaking medical products.

Plexus Research is a site management organization that operates the largest clinical trial network in South Australia with 10 clinics, 40 general practitioners (GPs) as investigators, and a database of 100,000 patients. The organization's future growth is slated to include 1,600 general practitioners, >400 clinics, and 1.3 million patients across Adelaide.

Pharmaceutical companies and CROs on the TriNetX network will be able to engage Plexus Research's general practitioner clinics and specialist clinics, enabling these sponsors to select study sites with eligible patients for investigative trials, and to pursue answers to clinical questions with de-identified patient data from South Australia.

"TriNetX is a key element of our strategy to improve access to clinical trials for Australians," said Suhit Anantula, Founding CEO of Plexus Research. "We are proud to be the first community-focused site management organization to join the TriNetX network in Australia."